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THE MUMPS SKIN TEST AND COMPLEMENT FIXATION TEST
AS A DIAGNOSTIC AID IN SARCOIDOSIS
EDWARD L. QUINN, M.D.*, DAVID C. BUNCH, M.D.* AND ELIZABETH M.
YAGLE, PH.D.t
The high incidence of both a positive mumps skin test and a positive mumps
complement fixation test in a majority of the adult population led us to examine
the correlation of these two tests in patients with sarcoidosis. Our preliminary
results indicated a different type of correlation of these two tests in sarcoid
patients and since these two tests are simple arid readily available, they may offer
a valuable diagnostic adjunct in patients suspected of sarcoidosis.
Enders (1, 2) and his co-workers in studies on the immunologic aspects of
mumps have shown that in adults approximately 75 to 85 per cent manifest
immunologic reactions indicative of previous mumps infection. Either the skin
test for mumps or the complement fixation test for mumps can be used to indicate
previous infection even though this had occurred many years before. In patients
with a positive mumps complement fixation test, 93 per cent also have a positive
skin test. Enders has found that approximately 60 per cent of adults have both a
positive skin test and a positive complement fixation test for mumps. As there is
no reason to suspect that patients with sarcoidosis would be any different in re-
spect to previous mumps infection, we should be able to predict that three out of
five sarcoid patients would react in this same manner unless the disease itself
altered this reactivity.
The frequency of negative skin test reaction especially to tuberculin has been a
noted feature in sarcoidosis and indeed an important diagnostic point in such
patients. The recent investigations of Israel and Sones, et al (3, 5) and
Friou (6), have revealed the following: 1) an inability of sarcoid patients to de-
velop and maintain a skin sensitivity to BCG vaccine; 2) the ability to transfer
passively tuberculin sensitivity to tuberculin negative patients with sarcoidosis,
indicating that the negative tuberculin reaction is not due to anticutins or other
inhibiting factors in the skin; 3) a singular lack of cutaneous reactions to oidio-
mycin, trichphytin, and mumps virus antigen, as well as tuberculin, in patients
with sarcoidosis; and 4) failure to develop skin sensitivity in normal fashion after
immunization with pertussis agglutinogen, although circulating antibodies appear
in normal titres.
This latter point constitutes the key in our present studies with the use of the
mumps skin test and complement fixation test in sarcoid patients in that we can
postulate that patients who have a positive complement fixation test to mumps
should usually, in contrast to normal adults, have a negative skin test to the
mumps antigen.
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MATERIALS AND METHODS
The diagnosis of sarcoidosis (3) can be established only by a combination of
clinical, roentgenologic, and histologic study. Sarcoidosis may be defined as a
disease characterized by the presence in various tissues of epithelioid cell tubercles
with inconspicuous necrosis, often having refractile or apparently calcified bodies
in the giant cells of the tubercles. Since a similar clinical and histologic appearance
has been produced by beryllium granulomatosis, silica granuloma of the skin,
histoplasmosis, tuberculosis, and other disease, it should be emphasized that the
discovery of sarcoid tubercles in excised surgical specimens does not permit a
diagnosis of sarcoidosis unless other clinical or roentgenologic evidence demon-
strates systemic involvement.
The criteria for diagnosis of sarcoidosis in the patients included in this report
has been based upon positive clinical, positive roentgenologic, and positive
histologic evidence plus negative cultures of biopsied material for tubercle
bacilli, negative evidence for histoplasmosis, and negative historical data for
beryllium granulomatosis.
The commercially available mumps allantoic fluid virus was used in perform-
ing the skin test and complement fixation test. The skin test was read in 48 hours
according to the technic of Enders (1) by the diameter of the zone of erythema,
10 mm. or greater being considered a positive test. (Actually in the patients herein
reported with negative tests, erythema was completely absent.) Since the skin
test material is antigenic, the blood for complement fixation was taken prior to
performing the skin test. A standard complement fixation test was used with a
2 or 4 plus reaction in a titre of 1:4 or higher being considered significant. This
technic is comparable to that of Enders (2) who considered a 1 or 2 plus reaction
in a 1:6 dilution as specifically indicating immunity to mumps.
RESULTS
Seven consecutive patients with sarcoidosis were tested (see Table I). All had
positive complement fixation tests and six of the seven had negative mumps skin
test. This indicates a failure of skin sensitivity reaction of 85 per cent compared to
the expected normal anergic response of 7 per cent. Thus, while a negative tuber-
culin and a negative mumps skin test would be a valuable diagnostic clue in
TABLE I
Sarcoidosis
Case
1
Purifie1 PoteinDerivative Mumps Skin Test Mumps ComplementFixation
— — 1:16
2 — — 1:4
3 — — 1:32
4 — — 1:4
5 — — 1:32
6 — + 1:8
7 + — 1:16
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TABLE II
Non-sarcoid cases
Case Mumps Skin Test Mumps Complement Fixation
1. Chronic lymphadenitis + 1:16
2. Chronic lymphadenitis + 1:32
3. Hodgkin's disease + 116
4. Granuloma of lung + —
5. Pulmonary fibrosis —
6. Carcinoma of lung + —
7. Periarteritis nodosa — —
8. Non-specific granulomata -- 1:16
sarcoidosis, much more weight could be given these tests if the patient exhibited
a positive mumps complement fixation test.
In contrast, in Table II, are listed eight consecutive patients studied during the
same period in which the diagnosis of sarcoidosis was suggested in the patient's
differential diagnosis, but in whom subsequent study, including biopsy, failed to
substantiate the diagnosis. Only the 8th patient showed a negative skin test in
the presence of a positive complement fixation test and it was a case character-
ized by recurrent fever with generalized non-specific focal granulomata involving
lymph nodes and liver. The lesions were riot characteristic of sarcoid and detailed
specific etiologic studies were all negative. The patient failed to respond to a
therapeutic trial of antibiotics including antituberculous therapy, but responded
to cortisone and has remained in remission for the past six months. Although this
patient's condition cannot be classified as sarcoidosis histologically, it resembles
this disease syndrome clinically more than any other.
We have studied other patients with these two tests, but these cases are incom-
plete for reporting here as biopsies were not done. We mention these cases only to
indicate the possible application of these tests and the lines of our current investi-
gations. They include patients with pulmonary fibrosis of unknown etiology,
idiopathic iritis, diagnostic problems of the collagen disease type, and certain
neoplasms involving the reticulo-endothelial system.
DrSCTJSSI0N
As sarcoidosis is not the only disease in which skin anergy is peculiar (e.g.
Hodgkin's disease) (7), further studies are needed to define the limitations and
value of the correlation of these two tests as an aid in diagnosis. They would
seem to offer a potential means of studying skin anergy in those patients cx-
hibiting a positive mumps complement fixation test and may therefore, have use-
fulness not only to the internist, but also to the allergist and others interested
in this phenomenon.
SUMMARY
In summary, we have found a high percentage of negative mumps skin tests
associated with positive mumps complement fixation tests in patients with sar-
coidosis in contrast to the usual correlated positivity of these two tests.
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